Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiallergic and antiinflammatory agents developed at Takeda

Sep. 23, 1998

New from Banyu: M3-selective muscarinic antagonists with excellent activity, improved safety

Sep. 22, 1998

TAN-2474 compounds from Gliocladium act as complement inhibitors

Sep. 22, 1998

Infasurf product launch delayed again

Sep. 21, 1998

Sankyo patents series with dual NK1/NK2-antagonist activity

Sep. 21, 1998

Treatment aimed at correcting underlying causes of CF enters phase II

Sep. 18, 1998

Stilbene analogue of pranlukast is a potent LTD4 antagonist with improved pharmacokinetics

Sep. 18, 1998

RPR-132703: a second-generation PDE4 inhibitor from Rhone-Roulenc Rorer

Sep. 18, 1998

Pharmacological characterization of new Astra agent for airways diseases presented at EFMC

Sep. 18, 1998

Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...